Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

APOC1 anticorps

Cet anticorps anti-APOC1 Polyclonal Chèvre (ABIN116544) détecte spécifiquement APOC1 dans WB, IP, EIA, IHC (p) et IHC (fro). L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN116544
2.710,77 €
Plus frais de livraison 40,00 € et TVA
1 mg
Destination: France
Envoi sous 17 jours ouvrables

Aperçu rapide pour APOC1 anticorps (ABIN116544)

Antigène

Voir toutes APOC1 Anticorps
APOC1 (Apolipoprotein C-I (APOC1))

Reactivité

  • 60
  • 5
  • 4
  • 4
  • 3
  • 1
Humain

Hôte

  • 54
  • 11
  • 9
  • 2
Chèvre

Clonalité

  • 53
  • 23
Polyclonal

Conjugué

  • 43
  • 7
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Cet anticorp APOC1 est non-conjugé

Application

  • 54
  • 47
  • 35
  • 32
  • 18
  • 16
  • 14
  • 5
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), Immunoprecipitation (IP), Enzyme Immunoassay (EIA), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Specificité

    This product has been prepared by immunoaffinity chromatography using immobilized antigens followed by extensive cross-adsorption against other apoLipoproteins and human serum proteins to remove any unwanted specificities. Typically less than 1 % cross reactivity against other types of apoLipoprotein was detected by ELISA against purified standards. This antibody reacts with human apoLipoprotein C-I and has negligible cross-reactivity with Type A-I, A-II, B, C-II, C-III, E and J apoLipoproteins. Specific cross reaction of anti-apoLipoprotein antibodies with antigens from other species has not been determined. Non-specific cross reaction of anti-apoLipoprotein antibodies with other human serum proteins is negligible.

    Purification

    Immunoaffinity chromatography

    Immunogène

    Apolipoprotein Type C-I produced synthetically in full-length form (not selected epitopes) using conventional peptide technology.
  • Indications d'application

    Suitable for indirect trapping ELISA (quantitation of antigen in serum using a standardcurve), Immunoprecipitation and Western blotting for highly sensitive qualitative analysis. This product has been tested by Immunohistochemistry using paraffin embedded tissues. Recommended dilutions: ELISA: 1/5,000-1/10,000. Western Blot: 1/5,000-1: 10,000. Immunohistochemistry: 1/50-1/200.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL (by UV absorbance at 280 nm)

    Buffer

    0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0 with 0.01 % sodium azide as preservative.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Store the antibody (undiluted) at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène

    APOC1 (Apolipoprotein C-I (APOC1))

    Autre désignation

    Apolipoprotein C I (Apo CI)

    Sujet

    The protein encoded by this gene is a member of the apolipoprotein C1 family. This gene is expressed primarily in the liver, and it is activated when monocytes differentiate into macrophages. A pseudogene of this gene is located 4 kb downstream in the same orientation, on the same chromosome. This gene is mapped to chromosome 19, where it resides within a apolipoprotein gene cluster. Alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. Apolipoprotein C-I appears to modulate the interaction of APOE with beta migrating VLDL and inhibit binding of beta VLDL to the LDL receptor related protein. At least 9 distinct polymorphic forms of apolipoproteins are known. The apolipoproteins act as stabilizers of the intact lipoprotein particles. Quantitative measurements of HDL, LDL and VLDL particles in human serum are often used to estimate an individuals' relative risk of coronary heart disease. In addition, quantitative immunological measurements of certain apolipoproteins (especially A1 and B) have been suggested to be more accurate estimators of coronary heart disease than measurements of lipoprotein particles (especially HDL and LDL).Synonyms: Apo-CI, Ap °C-I, Ap °C1, Apolipoprotein C-I, Apolipoprotein C1

    ID gène

    341

    NCBI Accession

    NP_001636

    UniProt

    P02654

    Pathways

    Apoptose
Vous êtes ici:
Chat with us!